MMPI's commercial debut

MMPI's commercial debut

This week's U.S. launch of CollaGenex Pharmaceuticals Inc.'s Periostat doxycycline to treat periodontal disease marks the first commercial availability of a product with matrix metalloproteinase inhibitory activity. Although Periostat is a member of a well-known antibiotic family - the tetracyclines - CGPI has found that the

Read the full 495 word article

How to gain access

Continue reading with a
two-week free trial.